New USP 797 Regulations May Create New Hazards for Compounding Pharmacy... ( AGAWAM Mass. Sept. 23 /- Though t...)

New USP 797 Regulations May Create New Hazards for Compounding Pharmacy Directors

Date:9/23/2008

AGAWAM, Mass., Sept. 23 /PRNewswire/ -- Though the new USP 797 regulations, which become effective June 1st, ease testing requirements, the impact of following the new minimums has the potential of creating new hazards for compounding pharmacy directors, warns Steven Wieczorek, Supervisor, Environmental Sciences, Microtest, Inc.

Issued by the U.S. Pharmacopoeia, the new version of USP 797 establishes bi-annual environmental sampling and testing as a minimum requirement, in place of the former monthly frequency. The regulations continue to require that pharmacies preparing compounded sterile preparations must have an effective plan and program that incorporate best practices and provide a clean, sterile working environment free of contamination.

Potential Hazards from Hidden Impacts

But Wieczorek says that adopting a bi-annual environmental testing program may impact a facility's capability to maintain compliance. "Compounding pharmacy directors need to recognize the series of potential hazards lurking for them within the 'hidden impacts' of the new regulations." Those hazards, he said, include:

-- Bi-annual testing will not capture seasonal blooms of yeast, fungi, and bacteria.

-- Problem tracking, diagnosis, and resolution will be difficult if environmental testing is conducted at six month intervals.

-- The development of trend data that shows important seasonal fluctuations will be impossible when conducting bi-annual environmental testing.

-- If a failure occurs during a bi-annual testing program, investigating up to 6 months of compounding activities and justifying what may or may not have been affected will be nearly impossible and extremely time consuming.

-- With a monthly testing program, a failure will require investigation of only 3 to 4 weeks of data and will be significantly easier -- saving large amounts of time and money. It will also help insure that the compounds prepared in your facilit
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. Autonomy Meridio Enables Extract Technology to Enhance Capabilities in Compliance With Manufacturing Regulations
2. Free White Paper Addresses Challenges of New FDA Regulations Awaiting Combo Product Manufacturers
3. CU scientists create worlds thinnest balloon -- just one atom thick
4. NPL to create encyclopedia for space nanomaterials
5. Using nanotechnology to create high-performance materials
6. New process creates 3-D nanostructures with magnetic materials
7. PacificGMP to Merge With Pacific Biopharma Group and Create Innovative US-Compliant cGMP Contract Biomanufacturing Facility in China
8. China Sun Group High-Tech Co. Completes Share Exchange to Create 100% Ownership in DLX Subsidiary
9. Monsantos Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America
10. Inclinix Expansion Creates New Position and Promotions
11. Weizmann Institute scientists create new nanotube structures

Post Your Comments:

New USP 797 Regulations May Create New Hazards for Compounding Pharmacy...( AGAWAM Mass. Sept. 23 /- Though t...)